Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. (Q37942790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

1 reference

title

Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Melissa Y Wei

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

474-483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21975919%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11883-011-0210-3

14 February 2020

exact match

0 references

cites work

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Changes in triglyceride levels and risk for coronary heart disease in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Trends in serum lipids and lipoproteins of adults, 1960-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Cardiovascular benefits of omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Meta-analysis: formulating, evaluating, combining, and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Influence of an algal triacylglycerol containing docosahexaenoic acid (22 : 6n-3) and docosapentaenoic acid (22 : 5n-6) on cardiovascular risk factors in healthy men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0210-3

Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects

21 January 2018

1 reference

12 December 2020

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

1 reference

12 December 2020

Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy.

1 reference

12 December 2020

Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome

1 reference

12 December 2020

LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women.

1 reference

12 December 2020

Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group

1 reference

12 December 2020

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

1 reference

12 December 2020

Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background.

1 reference

12 December 2020

Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids

1 reference

12 December 2020

Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.

1 reference

12 December 2020

Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients

1 reference

12 December 2020

Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.

1 reference

12 December 2020

The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.

1 reference

12 December 2020

n-3 fatty acids and serum lipoproteins: human studies

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020